Salvador Pedraza

Salvador Pedraza

Auto-generated profile, based on publicly available information

Salvador Pedraza

Department of Radiology (CDI) and IDIBAPS, Hospital Clínic, Barcelona, Spain

Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 August 2018 in New England Journal of Medicine
Verified
Journal Article
Closed access
GTGötz Thomalla
Götz Thomalla
CSClaus Z. Simonsen
Claus Z. Simonsen
FBFlorent Boutitie
Florent Boutitie
GAGrethe Andersen
Grethe Andersen
YBYves Berthezene
Yves Berthezene
CGChristian Gerloff
Christian Gerloff
Under current guidelines, intravenous thrombolysis is used to treat acute stroke only if it can be ascertained that the time since the onset of symptoms was less than 4.5 hours. We sought to determine whether patients with stroke with an unknown time of onset and features suggesting recent cerebral infarction on magnetic resonance imaging (MRI) would benefit from thrombolysis with the use of intravenous alteplase.

1 April 2006 in Stroke
Verified
Journal Article
Closed access
MWMax Wintermark
Max Wintermark
AFAdam E. Flanders
Adam E. Flanders
BVBirgitta Velthuis
Birgitta Velthuis
RMReto Meuli
Reto Meuli
MLMaarten van Leeuwen
Maarten van Leeuwen
SPSalvador Pedraza
Salvador Pedraza
Background and Purpose— Different definitions have been proposed to define the ischemic penumbra from perfusion-CT (PCT) data, based on parameters and thresholds tested only in small pilot studies. The purpose of this study was to perform a systematic evaluation of all PCT parameters (cerebral blood flow, volume [CBV], mean transit time [MTT], time-to-peak) in a large series of acute stroke patients, to determine which (combination of) parameters most accurately predicts infarct and penumbra. Methods— One hundred and thirty patients with symptoms suggesting hemispheric stroke ≤12 hours from onset were enrolled in a prospective multicenter trial. They all underwent admission PCT and follow-up diffusion-weighted imaging/fluid-attenuated inversion recovery (DWI/FLAIR); 25 patients also underwent admission DWI/FLAIR. PCT maps were assessed for absolute and relative reduced CBV, reduced cerebral blood flow, increased MTT, and increased time-to-peak. Receiver-operating characteristic curve analysis was performed to determine the most accurate PCT parameter, and the optimal threshold for each parameter, using DWI/FLAIR as the gold standard. Results— The PCT parameter that most accurately describes the tissue at risk of infarction in case of persistent arterial occlusion is the relative MTT (area under the curve=0.962), with an optimal threshold of 145%. The PCT parameter that most accurately describes the infarct core on admission is the absolute CBV (area under the curve=0.927), with an optimal threshold at 2.0 ml×100 g −1 . Conclusion— In a large series of 130 patients, the optimal approach to define the infarct and the penumbra is a combined approach using 2 PCT parameters: relative MTT and absolute CBV, with dedicated thresholds.

1 February 2009 in The Lancet Neurology
Verified
Journal Article
Closed access
WHWerner Hacke
Werner Hacke
AFAnthony J Furlan
Anthony J Furlan
YAYasir Al-Rawi
Yasir Al-Rawi
ADAntoni Davalos
Antoni Davalos
JFJochen B Fiebach
Jochen B Fiebach
SWSteven Warach
Steven Warach

1 September 2005 in Stroke
Verified
Journal Article
Closed access
PDF file
MWMax Wintermark
Max Wintermark
MSMusa Sesay
Musa Sesay
EBEmmanuel Barbier
Emmanuel Barbier
KBKatalin Borbély
Katalin Borbély
WDWilliam P. Dillon
William P. Dillon
HYHoward Yonas
Howard Yonas
Background and Purpose— Numerous imaging techniques have been developed and applied to evaluate brain hemodynamics. Among these are positron emission tomography, single photon emission computed tomography, Xenon-enhanced computed tomography, dynamic perfusion computed tomography, MRI dynamic susceptibility contrast, arterial spin labeling, and Doppler ultrasound. These techniques give similar information about brain hemodynamics in the form of parameters such as cerebral blood flow or cerebral blood volume. All of them are used to characterize the same types of pathological conditions. However, each technique has its own advantages and drawbacks. Summary of Review— This article addresses the main imaging techniques dedicated to brain hemodynamics. It represents a comparative overview established by consensus among specialists of the various techniques. Conclusions— For clinicians, this article should offer a clearer picture of the pros and cons of currently available brain perfusion imaging techniques and assist them in choosing the proper method for every specific clinical setting.

1 June 2014 in Stroke
Verified
Journal Article
Closed access
BCBastian Cheng
Bastian Cheng
NFNils Daniel Forkert
Nils Daniel Forkert
MZMelissa Zavaglia
Melissa Zavaglia
CHClaus C. Hilgetag
Claus C. Hilgetag
AGAmir Golsari
Amir Golsari
GTGötz Thomalla
Götz Thomalla
Background and Purpose—: In the early days after ischemic stroke, information on structural brain damage from MRI supports prognosis of functional outcome. It is rated widely by the modified Rankin Scale that correlates only moderately with lesion volume. We therefore aimed to elucidate the influence of lesion location from early MRI (days 2–3) on functional outcome after 1 month using voxel-based lesion symptom mapping. Methods—: We analyzed clinical and MRI data of patients from a prospective European multicenter stroke imaging study (I-KNOW). Lesions were delineated on fluid-attenuated inversion recovery images on days 2 to 3 after stroke onset. We generated statistic maps of lesion contribution related to clinical outcome (modified Rankin Scale) after 1 month using voxel-based lesion symptom mapping. Results—: Lesion maps of 101 patients with middle cerebral artery infarctions were included for analysis (right-sided stroke, 47%). Mean age was 67 years, median admission National Institutes of Health Stroke Scale was 11. Mean infarct volumes were comparable between both sides (left, 37.5 mL; right, 43.7 mL). Voxel-based lesion symptom mapping revealed areas with high influence on higher modified Rankin Scale in regions involving the corona radiata, internal capsule, and insula. In addition, asymmetrically distributed impact patterns were found involving the right inferior temporal gyrus and left superior temporal gyrus. Conclusions—: In this group of patients with stroke, characteristic lesion patterns in areas of motor control and areas involved in lateralized brain functions on early MRI were found to influence functional outcome. Our data provide a novel map of the impact of lesion localization on functional stroke outcome as measured by the modified Rankin Scale.

1 October 2007 in Stroke
Verified
Journal Article
Closed access
JFJens Fiehler
Jens Fiehler
GAGregory W. Albers
Gregory W. Albers
JBJean-Martin Boulanger
Jean-Martin Boulanger
LDLaurent Derex
Laurent Derex
AGAchim Gass
Achim Gass
JTJohannes Trenkler
Johannes Trenkler
Background and Purpose— There has been speculation that the risk of secondary symptomatic intracranial hemorrhage (SICH) may be increased after thrombolytic therapy in ischemic stroke patients who have cerebral microbleeds (CMBs) on T2*-weighted magnetic resonance imaging. Because of this concern, some centers withhold potentially beneficial thrombolytic therapy from these patients. Methods— We analyzed magnetic resonance imaging data acquired within 6 hours after symptom onset from 570 ischemic stroke patients treated with intravenous tissue plasminogen activator in 13 centers in Europe, North America, and Asia. Baseline T2*-weighted magnetic resonance images were evaluated for the presence of CMBs. The primary end point was SICH, defined as clinical deterioration with an increase in the National Institutes of Health Stroke Scale score by ≥4 points, temporally related to a parenchymal hematoma on follow-up-imaging. Results— A total of 242 CMBs were detected in 86 of 570 patients (15.1%). The number of CMBs ranged from 1 to 77 in the individual patient, with ≥5 CMBs in 6 of 570 patients (1.1%). Proportions of patients with SICH were 5.8% (95% CI, 1.9 to 13.0) in the presence of CMBs and 2.7% (95% CI, 1.4 to 4.5) in patients without CMBs ( P =0.170, Fisher’s exact test), resulting in no significant absolute increase in the risk of SICH of 3.1% (95% CI, −2.0 to 8.3). Conclusions— The data suggest that if there is any increased risk of SICH attributable to CMBs, it is likely to be small and unlikely to exceed the benefits of thrombolytic therapy. No reliable conclusion regarding risk in the rare patient with multiple CMBs can be reached.